Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Beauvericin

Copy Product Info
😃Good
Catalog No. T14523Cas No. 26048-05-5

Beauvericin, a Fusarium mycotoxin, inhibits acyl-CoA:cholesterol acyltransferase (ACAT) in rat liver microsomal enzyme assays with an IC50 value of 3 μM.

Beauvericin

Beauvericin

Copy Product Info
😃Good
Catalog No. T14523Cas No. 26048-05-5
Beauvericin, a Fusarium mycotoxin, inhibits acyl-CoA:cholesterol acyltransferase (ACAT) in rat liver microsomal enzyme assays with an IC50 value of 3 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$64In StockIn Stock
5 mg$148-In Stock
10 mg$218-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:≥98%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Beauvericin AI Summary
Beauvericin exhibits significant antifungal activity against Candida albicans ATCC 24433, with a MIC of >100.0 μg/mL in a standard broth microdilution assay. Its antifungal efficacy improves substantially when combined with fluconazole, reducing the MIC to 1.3 μg/mL, indicative of a synergistic effect. This synergy is further supported by a low fractional inhibition concentration ratio and index. The compound also demonstrates antibiofilm activity, achieving a MIC=>80 of 40.0 μg/mL in the presence of fluconazole, again displaying synergistic properties and potentiation of fluconazole's activity. In addition to its antifungal properties, Beauvericin shows antiproliferative effects against various cell lines. It exhibits an IC50 of 4300.0 nM against human Huh-7 liver cancer cells, 8700.0 nM against rat MRMT-1 mammary carcinoma cells, and 1000.0 nM against human HepG2 liver cancer cells, as determined by the CCK-8 assay after 48 hours of treatment. Furthermore, the compound inhibits SOAT activity in mouse J774 macrophages with an IC50 of 5600.0 nM. Overall, Beauvericin demonstrates promising antifungal, antibiofilm, and antiproliferative activities, making it a potential candidate for further development in both antimicrobial and anticancer therapies..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Beauvericin, a Fusarium mycotoxin, inhibits acyl-CoA:cholesterol acyltransferase (ACAT) in rat liver microsomal enzyme assays with an IC50 value of 3 μM.
Targets&IC50
ACAT:3 μM
Chemical Properties
Molecular Weight783.95
FormulaC45H57N3O9
Cas No.26048-05-5
SmilesCC(C)[C@H]1OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](OC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](OC(=O)[C@H](Cc2ccccc2)N(C)C1=O)C(C)C)C(C)C
Relative Density.1.31g/cm3
Sequencecyclo[D-OVal-N(Me)Phe-D-OVal-N(Me)Phe-D-OVal-N(Me)Phe]
Sequence Shortcyclo(VFVFVF)
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 78.4 mg/mL (100.01 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2756 mL6.3780 mL12.7559 mL63.7796 mL
5 mM0.2551 mL1.2756 mL2.5512 mL12.7559 mL
10 mM0.1276 mL0.6378 mL1.2756 mL6.3780 mL
20 mM0.0638 mL0.3189 mL0.6378 mL3.1890 mL
50 mM0.0255 mL0.1276 mL0.2551 mL1.2756 mL
100 mM0.0128 mL0.0638 mL0.1276 mL0.6378 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Beauvericin | purchase Beauvericin | Beauvericin cost | order Beauvericin | Beauvericin chemical structure | Beauvericin formula | Beauvericin molecular weight